Evaluation of Recombinant Growth Hormone Therapy to Prevent Muscle Atrophy in Patients With Anterior Cruciate Ligament Tears
Phase of Trial: Phase II
Latest Information Update: 01 Feb 2018
At a glance
- Drugs Somatrogon (Primary)
- Indications Knee injuries
- Focus Therapeutic Use
- 27 Jan 2018 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.
- 27 Jan 2018 Planned primary completion date changed from 1 May 2018 to 1 Dec 2019.
- 10 Jun 2017 Biomarkers information updated